REFERENCES
- Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG. Genetic disorders of renal electrolyte transport. N Engl J Med. 1999;340:1177–1187.
- O’Shaughnessy KM, Karet FE. Salt handling and hypertension. J Clin Invest. 2004;113:1075–1081.
- Graziani G, Fedeli C, Moroni L, Cosmai L, Badalamenti S, Ponticelli C. Gitelman syndrome: Pathophysiological and clinical aspects. QJM. 2010;103:741–748.
- Wermers RA, Kearns AE, Jenkins GD, Melton III LJ. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med. 2007;120(911):e9–e15.
- Brickman AS, Massry SG, Colburn JW. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: Study on mechanisms. J Clin Invest. 1972;51:945–954.
- Middler S, Pak CY, Murad F, Bartter FC. Thiazide diuretics and calcium metabolism. Metabolism. 1973;22:139–146.
- Nijenhuis T, Vallon V, van der Kemp AW, Loffing J,Hoenderop JG, Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115:1651–1658.
- Bazzini C, Vezzoli V, Sironi C, . Thiazide-sensitive NaCl-cotransporter in the intestine: Possible role of hydrochlorothiazide in the intestinal Ca2+ uptake. J Biol Chem. 2005;280:19902–19910.
- Heath III H. Postural and venous stasis-induced changes in total calcium. Mayo Clin Proc. 2005;80:1101.
- Bianchetti MG, Bettinelli A, Casez JP, . Evidence for disturbed regulation of calciotropic hormone metabolism in Gitelman syndrome. J Clin Endocrinol Metab. 1995;80:224–228.
- Bettinelli A, Basilico E, Metta MG, Borella P, Jaeger P, Bianchetti MG. Magnesium supplementation in Gitelman syndrome. Pediatr Nephrol. 1999;13:311–314.
- Grant FD, Conlin PR, Brown EM. Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans. J Clin Endocrinol Metab. 1990;71:370–378.
- Nussbaum SR, Zahradnik RJ, Lavigne JR, . Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987;33:1364–1367.
- Silverberg SJ. Diagnosis, natural history, and treatment of primary hyperparathyroidism. Cancer Treat Res. 1997;89:163–181.
- Fuleihan Gel H. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res. 2002;17(2):N51–N56.
- Holmes DT, Levin A, Forer B, Rosenberg F. Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients. Clin Chem. 2005;51:915–917.
- Kinoshita Y, Taguchi M, Takeshita A, Miura D, Tomikawa S, Takeuchi Y. 1,25-Dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis. J Clin Endocrinol Metab. 2005;90:6727–6731.
- Rude RK. Magnesium deficiency in parathyroid function. In: Bilzekian JP, Marcus R, Levine MA, eds. The Parathyroids. New York: Raven Press; 2001:763–777.